In chemotherapy-induced cardiotoxicity and mitigation
Scholar“Research focused on Chemotherapy-induced cardiotoxicity and mitigation and adjacent fields.”
Egypt10
H-index
365
Citations
Mona has not officially claimed their profile. If you are Mona, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
ona M. Saber is a researcher working on Chemotherapy-induced cardiotoxicity and mitigation. A fuller summary will appear once they update their profile.
Mona's work has been cited 365 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
Research themes (UN SDGs)
Biomedicine & Pharmacotherapy, Chemotherapy-induced cardiotoxicity and mitigation
Current Molecular Pharmacology, Inflammation biomarkers and pathways
Cell Biochemistry and Biophysics, Cancer-related molecular mechanisms research
Journal of Drug Delivery Science and Technology, Streptococcal Infections and Treatments
Asian Pacific Journal of Cancer Prevention, Chemotherapy-induced organ toxicity mitigation
Advances in experimental medicine and biology, Pharmacological Effects of Natural Compounds
International Journal of Pharmaceutics X, Metabolism, Diabetes, and Cancer
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Free to claim · takes a minute to verify it’s you
